Fidelity Investments’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.85B | Sell |
|
|||||
|
2025
Q1 | $3.75B | Sell |
|
|||||
|
2024
Q4 | $3.71B | Sell |
|
|||||
|
2024
Q3 | $4.89B | Sell |
|
|||||
|
2024
Q2 | $5.03B | Buy |
|
|||||
|
2024
Q1 | $4.46B | Sell |
|
|||||
|
2023
Q4 | $5.28B | Sell |
|
|||||
|
2023
Q3 | $4.99B | Sell |
|
|||||
|
2023
Q2 | $5.15B | Sell |
|
|||||
|
2023
Q1 | $5.13B | Sell |
|
|||||
|
2022
Q4 | $5.16B | Buy |
|
|||||
|
2022
Q3 | $5.03B | Buy |
|
|||||
|
2022
Q2 | $4.72B | Buy |
|
|||||
|
2022
Q1 | $3.44B | Buy |
|
|||||
|
2021
Q4 | $2B | Buy |
|
|||||
|
2021
Q3 | $885M | Sell |
|
|||||
|
2021
Q2 | $1.18B | Sell |
|
|||||
|
2021
Q1 | $2.19B | Sell |
|
|||||
|
2020
Q4 | $3.11B | Sell |
|
|||||
|
2020
Q3 | $5.48B | Buy |
|
|||||
|
2020
Q2 | $5.59B | Sell |
|
|||||
|
2020
Q1 | $5.39B | Sell |
|
|||||
|
2019
Q4 | $5.22B | Sell |
|
|||||
|
2019
Q3 | $4.19B | Buy |
|
|||||
|
2019
Q2 | $4.53B | Buy |
|
|||||
|
2019
Q1 | $4.49B | Buy |
|
|||||
|
2018
Q4 | $3.39B | Buy |
|
|||||
|
2018
Q3 | $3.48B | Buy |
|
|||||
|
2018
Q2 | $2.78B | Sell |
|
|||||
|
2018
Q1 | $2.82B | Buy |
|
|||||
|
2017
Q4 | $2.51B | Buy |
|
|||||
|
2017
Q3 | $2.52B | Sell |
|
|||||
|
2017
Q2 | $2.38B | Sell |
|
|||||
|
2017
Q1 | $2.06B | Sell |
|
|||||
|
2016
Q4 | $1.48B | Sell |
|
|||||
|
2016
Q3 | $2B | Buy |
|
|||||
|
2016
Q2 | $1.91B | Buy |
|
|||||
|
2016
Q1 | $1.2B | Buy |
|
|||||
|
2015
Q4 | $1.89B | Sell |
|
|||||
|
2015
Q3 | $1.84B | Buy |
|
|||||
|
2015
Q2 | $2.04B | Buy |
|
|||||
|
2015
Q1 | $1.82B | Buy |
|
|||||
|
2014
Q4 | $1.72B | Buy |
|
|||||
|
2014
Q3 | $1.57B | Buy |
|
|||||
|
2014
Q2 | $1.23B | Buy |
|
|||||
|
2014
Q1 | $467M | Buy |
|
|||||
|
2013
Q4 | $425M | Sell |
|
|||||
|
2013
Q3 | $685M | Sell |
|
|||||
|
2013
Q2 | $772M | Buy |
|